GPVI antagonist 3 is a potent antagonist of Glycoprotein VI (GPVI), a major platelet collagen receptor and a promising target for effective and safe antithrombotic therapy; it exhibits antiplatelet activity with IC50 values of 1.01 μM against collagen, 1.92 μM against CRP, 7.24 μM against convulxin, and 51.74 μM against thrombin.